FDA Panel Weighs First mRNA-Based Flu Vaccine in Historic Review
The FDA is reviewing a first-of-its-kind flu vaccine that uses mRNA technology, similar to COVID-19 vaccines. This groundbreaking vaccine could offer enhanced protection against the flu. The FDA panel’s decision is crucial for its potential approval and use.
FDA Panel Weighs First mRNA-Based Flu Vaccine in Historic Review Read Post ยป